Abstract:BackgroundGlomerulonephritis, which causes inflammation in glomeruli, is a common cause of end-stage renal failure. Severe and prolonged inflammation can damage glomeruli and lead to kidney fibrosis. Connective tissue growth factor (CTGF) is a member of the CCN matricellular protein family, consisting of four domains, that regulates the signaling of other growth factors and promotes kidney fibrosis.Main body of the abstractCTGF can simultaneously interact with several factors with its four domains. The microenvironment differs depending on the types of cells and tissues and differentiation stages of these cells. The diverse biological actions of CTGF on various types of cells and tissues depend on this difference in microenvironment. In the kidney, CTGF is expressed at low levels in normal condition and its expression is upregulated by kidney fibrosis. CTGF expression is known to be upregulated in the extra-capillary and mesangial lesions of glomerulonephritis in human kidney biopsy samples. In addition to involvement in fibrosis, CTGF modulates the expression of inflammatory mediators, including cytokines and chemokines, through distinct signaling pathways, in various cell systems. In anti-glomerular basement membrane (GBM) glomerulonephritis, systemic CTGF knockout (Rosa-CTGF cKO) mice exhibit 50% reduction of proteinuria and decreased crescent formation and mesangial expansion compared with control mice. In addition to fibrotic markers, the glomerular mRNA expression of Ccl2 is increased in the control mice with anti-GBM glomerulonephritis, and this increase is reduced in Rosa-CTGF cKO mice with nephritis. Accumulation of MAC2-positive cells in glomeruli is also reduced in Rosa-CTGF cKO mice. These results suggest that CTGF may be required for the upregulation of Ccl2 expression not only in anti-GBM glomerulonephritis but also in other types of glomerulonephritis, such as IgA nephropathy; CTGF expression and accumulation of macrophages in the mesangial area have been documented in these glomerular diseases. CTGF induces the expression of inflammatory mediators and promotes cell adhesion.Short conclusionCTGF plays an important role in the development of glomerulonephritis by inducing the inflammatory process. CTGF is a potentiate target for the treatment of glomerulonephritis.

Connective tissue growth factor (CTGF) in age-related vascular pathologies

Connective Tissue Growth Factor: From Molecular Understandings to Drug Discovery

Advanced Glycation End-Products Induce Tubular CTGF Via TGF-beta-independent Smad3 Signaling.

Connective Tissue Growth Factor Expression And Smad Signaling During Mouse Heart Development And Myocardial Infarction

Mechanical regulation of the Cyr61/CCN1 and CTGF/CCN2 proteins

CTGF in kidney fibrosis and glomerulonephritis

CTGF as a multifunctional molecule for cartilage and a potential drug for osteoarthritis

CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis

Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases

TGF-β Signaling and Vascular Morphogenesis

Recent Progress in Vascular Aging: Mechanisms and Its Role in Age-related Diseases

Selective deletion of connective tissue growth factor attenuates experimentally-induced pulmonary fibrosis and pulmonary arterial hypertension

Targeting CTGF in Cancer: An Emerging Therapeutic Opportunity

Regulation, Diseases, and Drug Discovery

Fell-Muir lecture: Connective tissue growth factor (CCN2) -- a pernicious and pleiotropic player in the development of kidney fibrosis

Functional Characteristics of Connective Tissue Growth Factor on Human Tenon’s Capsule Fibroblast

Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis

CTGF/CCN2 from Skeletal Muscle to Nervous System: Impact on Neurodegenerative Diseases

The mechanism of profibrotic effect of connective tissue growth factor

TGF-β Signaling in Control of Cardiovascular Function

Connective tissue growth factor expression is decreased in acute ascending aortic dissections and increased in degenerative ascending aortic aneurysms